rheumatology
Rheumatoid arthritis

Liver toxicity warning for tocilizumab


Serious drug-induced liver injury, including acute liver failure, hepatitis and jaundice, have been observed with the biologic tocilizumab (Actemra), according to the Therapeutic Goods Administration (TGA) In an advisory statement to health professionals, the TGA says serious hepatotoxicity is considered rare, but in some cases treatment has required liver transplant. Tocilizumab is approved for use ...

Already a member?

Enter your email to keep reading.


OR